000 | 01030 a2200313 4500 | ||
---|---|---|---|
005 | 20250513201151.0 | ||
264 | 0 | _c20000127 | |
008 | 200001s 0 0 eng d | ||
022 | _a0362-5664 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSinka, E | |
245 | 0 | 0 |
_aClinical Neuropharmacology patient management series. Alzheimer's disease. _h[electronic resource] |
260 |
_bClinical neuropharmacology _c |
||
300 |
_a307-11 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAlanine Transaminase _xblood |
650 | 0 | 4 |
_aAlzheimer Disease _xblood |
650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
650 | 0 | 4 | _aCase Management |
650 | 0 | 4 |
_aCholinesterase Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aClozapine _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aTacrine _xtherapeutic use |
650 | 0 | 4 |
_aVitamin E _xtherapeutic use |
700 | 1 | _aForchetti, C M | |
773 | 0 |
_tClinical neuropharmacology _gvol. 22 _gno. 6 _gp. 307-11 |
|
999 |
_c10581566 _d10581566 |